Evidence map›Paper›PMID 25091054›Full record

ReviewCurrent osteoporosis reports2014

MicroRNAs in cartilage development, homeostasis, and disease.

Fatemeh Mirzamohammadi, Garyfallia Papaioannou, Tatsuya Kobayashi

Open access · greenAbstract readReview
In one paragraph

Review in Current osteoporosis reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 90 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Epigallocatechin-3-Pharmaceutical biology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. miR-335-5P contributes to human osteoarthritis by targeting HBP1.Experimental and therapeutic medicine · 2021
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Fatemeh MirzamohammadiEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, 50 Blossom Street, Boston, MA, 02114, USA.
Garyfallia Papaioannou
Tatsuya Kobayashi
Massachusetts General Hospital · USHarvard University · US

Funding

Role of miR-17-92 miRNAs in skeletal development and bone homeostasisR01AR056645 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI KOBAYASHI, TATSUYA · 2010 to 2020
$4.1M
Small RNAs in skeletogenesisR21AR054500 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI KOBAYASHI, TATSUYA · 2007 to 2008
$401k
NIAMS NIH HHS AR054500NIAMS NIH HHS AR056645NIAMS NIH HHS R01 AR056645
6 · The paper itself

Abstract

microRNAs (miRNAs) regulate gene expression mainly at the posttranscriptional level. Many different miRNAs are expressed in chondrocytes, and each individual miRNA can regulate hundreds of target genes, creating a complex gene regulatory network. Experimental evidence suggests that miRNAs play significant roles in various aspects of cartilage development, homeostasis, and pathology. The possibility that miRNAs can be novel therapeutic targets for cartilage diseases led to vigorous investigations to understand the role of individual miRNAs in skeletal tissues. Here, we summarize our current understanding of miRNAs in chondrocytes and cartilage. In the first part, we discuss roles of miRNAs in growth plate development and chondrocyte differentiation. In the second part, we put a particular focus on articular cartilage and discuss the significance of variety of findings in the context of osteoarthritis, the most common degenerative joint disease.

Indexed as

Cartilage, ArticularCell DifferentiationCell ProliferationChondrocytesGrowth PlateHomeostasisHumansMicroRNAsOsteoarthritisMicroRNAs

Identifiers

PMID25091054
PMCPMC4234170
OpenAlexW2130103573

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.